DexCom (DXCM) To Report Q1 Earnings: What's In The Offing?
Zacks Investment Research | Apr 25, 2019 03:29AM ET
DexCom, Inc.’s (NASDAQ:DXCM) first-quarter 2019 results are scheduled to release on May 1, after market close. While the company’s solid sensor volumes are expected to drive to-be-reported quarter results, stiff competition in the glucose monitoring space is concerning.
Notably, the company has average earnings surprise of 132.3% for the trailing four quarters.
Let’s see how things are shaping up prior to the earnings release.
Which Way Are Estimates Treading?
The Zacks Consensus Estimate for first-quarter is pegged at a loss of 17 cents. The same for revenues is pinned at $246.5 million, suggesting a 33.7% improvement year over year.
Sensor Segment to Boost Results
DexCom's unique sensor technology has lent it a competitive edge in the MedTech space.
The company is expected to gain from strong demand for the G6 sensors. In fact, these sensors are likely to rake in huge profits for the quarter to be reported. By late 2018, management at DexCom had announced that the G6 system is available in 14 countries and the company has continued to roll it out globally since then. Meanwhile, DexCom’s Insulet and Lilly diabetes management products continue to progress well.
Additionally, the acquisition of TypeZero in the recent past has helped solidify the company’s product pipeline, which might drive results in the quarter to be reported.
The Zacks Consensus Estimate for the segment’s first-quarter revenues stands at $203 million, suggesting a significant 53.8% rise year over year.
DexCom, Inc. Price and EPS Surprise
Earnings ESP Filter .Zacks Rank: DexCom carries a Zacks Rank #3. You can see .
Please note that we caution against stocks with a Zacks Rank #4 or 5 (Sell-rated) going into the earnings announcement, especially when the company is seeing negative estimate revisions.
Stocks Worth a Look
Here are a few stocks from the broader medical space that are likely to post an earnings beat this season.
Cardinal Health (NYSE:CAH) has an Earnings ESP of +1.13% and a Zacks Rank #3.
Medidata Solutions (NASDAQ:MDSO) has an Earnings ESP of +12.31% and a Zacks Rank #3.
LHC Group (NASDAQ:LHCG) has an Earnings ESP of +0.56% and a Zacks Rank #3.
Radical New Technology Creates $12.3 Trillion Opportunity
Imagine buying Microsoft (NASDAQ:MSFT) stock in the early days of personal computers… or Motorola (NYSE:MSI) after it released the world’s first cell phone. These technologies changed our lives and created massive profits for investors.
Today, we’re on the brink of the next quantum leap in technology. 7 innovative companies are leading this “4th Industrial Revolution” - and early investors stand to earn the biggest profits.
Get The News You Want
Zacks Investment Research
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.